➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Dow
Boehringer Ingelheim
Harvard Business School
Merck

Last Updated: October 28, 2020

DrugPatentWatch Database Preview

PROCAINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Procaine Hydrochloride patents expire, and when can generic versions of Procaine Hydrochloride launch?

Procaine Hydrochloride is a drug marketed by Abraxis Pharm, Bel Mar, Elkins Sinn, Gd Searle Llc, Hospira, Miles, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in PROCAINE HYDROCHLORIDE is epinephrine; procaine hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the epinephrine; procaine hydrochloride profile page.

Summary for PROCAINE HYDROCHLORIDE
Drug patent expirations by year for PROCAINE HYDROCHLORIDE
Recent Clinical Trials for PROCAINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Oregon Health and Science UniversityEarly Phase 1
McGill University Health CenterN/A
The Adelaide and Meath Hospital, incorporating The National Children's HospitalN/A

See all PROCAINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for PROCAINE HYDROCHLORIDE

US Patents and Regulatory Information for PROCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080384-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 083535-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 083315-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080421-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080416-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar PROCAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; procaine hydrochloride INJECTABLE;INJECTION 080759-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 083315-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Baxter
AstraZeneca
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.